X0206 3 2017-11-01 0 0001624658 Allena Pharmaceuticals, Inc. ALNA 0001341382 Topper James N C/O ALLENA PHARMACEUTICALS, INC. ONE NEWTON EXECUTIVE PARK, SUITE 202 NEWTON MA 02459 1 0 1 0 Stock Option (Right to Buy) 5.72 2027-09-26 Common Stock 20364 D Series A Preferred Stock Common Stock 1466805 I By: Frazier Healthcare VI, L.P. Series B Preferred Stock Common Stock 1109159 I By: Frazier Healthcare VI, L.P. Series C Preferred Stock Common Stock 254409 I By: Frazier Healthcare VI, L.P. These shares vest annual over a 3 (three) year period beginning on September 26, 2018. All series of Convertible Preferred Stock will automatically convert into Allena Pharmaceuticals, Inc. (the "Issuer") common stock on a 4.174-for-1 basis at any time at the holders's election, and automatically upon the closing of the Issuer's initial public offering, and has no expiration date. These shares are held directly by Frazier Healthcare VI, L.P. The general partner of Frazier Healthcare VI, L.P is FHM VI, LLC, a Delaware limited partnership. The general partner of FHM VI, L.P. is FHM VI, LLC, a Delaware limited liability company. The Reporting Person, Alan Frazier, Nader Naini, Nathan Every and Patrick Heron are all of the members of FHM VI, LLC. The Reporting Person and the members disclaim beneficial ownership of such shares except to the extent of their pecuniary interest in such shares, if any, and this report shall not be deemed ad admission that it is or he is the beneficial owner of such shares. Exhibit 24 - Power of Attorney /s/ Kevin Brennan, attorney-in-fact 2017-11-01